These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9067475)

  • 1. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats.
    Tasaki K; Ruetzler CA; Ohtsuki T; Martin D; Nawashiro H; Hallenbeck JM
    Brain Res; 1997 Feb; 748(1-2):267-70. PubMed ID: 9067475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of TNF binding protein in focal cerebral ischemia.
    Nawashiro H; Martin D; Hallenbeck JM
    Brain Res; 1997 Dec; 778(2):265-71. PubMed ID: 9459543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor necrosis factor and amelioration of brain infarction in mice.
    Nawashiro H; Martin D; Hallenbeck JM
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):229-32. PubMed ID: 9040503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury.
    Barone FC; Arvin B; White RF; Miller A; Webb CL; Willette RN; Lysko PG; Feuerstein GZ
    Stroke; 1997 Jun; 28(6):1233-44. PubMed ID: 9183357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat.
    Dawson DA; Martin D; Hallenbeck JM
    Neurosci Lett; 1996 Oct; 218(1):41-4. PubMed ID: 8939476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
    Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
    Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed treatment with nicotinamide (vitamin B3) reduces the infarct volume following focal cerebral ischemia in spontaneously hypertensive rats, diabetic and non-diabetic Fischer 344 rats.
    Sakakibara Y; Mitha AP; Ayoub IA; Ogilvy CS; Maynard KI
    Brain Res; 2002 Mar; 931(1):68-73. PubMed ID: 11897090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
    Neurol Med Chir (Tokyo); 1996 Mar; 36(3):151-5. PubMed ID: 8869150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-α inhibition attenuates middle cerebral artery remodeling but increases cerebral ischemic damage in hypertensive rats.
    Pires PW; Girgla SS; Moreno G; McClain JL; Dorrance AM
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H658-69. PubMed ID: 25015967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFR1 upregulation mediates tolerance after brain ischemic preconditioning.
    Pradillo JM; Romera C; Hurtado O; Cárdenas A; Moro MA; Leza JC; Dávalos A; Castillo J; Lorenzo P; Lizasoain I
    J Cereb Blood Flow Metab; 2005 Feb; 25(2):193-203. PubMed ID: 15647744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell permeable exogenous ceramide reduces infarct size in spontaneously hypertensive rats supporting in vitro studies that have implicated ceramide in induction of tolerance to ischemia.
    Furuya K; Ginis I; Takeda H; Chen Y; Hallenbeck JM
    J Cereb Blood Flow Metab; 2001 Mar; 21(3):226-32. PubMed ID: 11295877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular hemodynamics and ischemic tolerance: lipopolysaccharide-induced resistance to focal cerebral ischemia is not due to changes in severity of the initial ischemic insult, but is associated with preservation of microvascular perfusion.
    Dawson DA; Furuya K; Gotoh J; Nakao Y; Hallenbeck JM
    J Cereb Blood Flow Metab; 1999 Jun; 19(6):616-23. PubMed ID: 10366191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia.
    Günther A; Küppers-Tiedt L; Schneider PM; Kunert I; Berrouschot J; Schneider D; Rossner S
    Eur J Neurosci; 2005 Jun; 21(11):3189-94. PubMed ID: 15978027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of tumor necrosis factor (TNF) in the febrile and metabolic responses of rats to intraperitoneal injection of a high dose of lipopolysaccharide.
    Töllner B; Roth J; Störr B; Martin D; Voigt K; Zeisberger E
    Pflugers Arch; 2000 Oct; 440(6):925-32. PubMed ID: 11041560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
    Slivka AP; Murphy EJ
    Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in infarct evolution between lipopolysaccharide-induced tolerant and nontolerant conditions to focal cerebral ischemia.
    Furuya K; Zhu L; Kawahara N; Abe O; Kirino T
    J Neurosurg; 2005 Oct; 103(4):715-23. PubMed ID: 16266055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated cerebral ischemic injury by activated macrophages/microglia after lipopolysaccharide microinjection into rat corpus callosum.
    Lee JC; Cho GS; Kim HJ; Lim JH; Oh YK; Nam W; Chung JH; Kim WK
    Glia; 2005 Apr; 50(2):168-81. PubMed ID: 15702482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporary focal cerebral ischemia in spontaneously hypertensive rats: the effect of ibuprofen on infarct volume.
    Cole DJ; Patel PM; Reynolds L; Drummond JC; Marcantonio S
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1713-7. PubMed ID: 8371169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma.
    Zimmermann C; Ginis I; Furuya K; Klimanis D; Ruetzler C; Spatz M; Hallenbeck JM
    Brain Res; 2001 Mar; 895(1-2):59-65. PubMed ID: 11259760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.
    Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.